Cohort profile for the Loma Linda University Health BREATHE programme: a model to study continuously incentivised employee smoking cessation.
COVID-19
EPIDEMIOLOGY
PUBLIC HEALTH
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
21 04 2022
21 04 2022
Historique:
entrez:
22
4
2022
pubmed:
23
4
2022
medline:
26
4
2022
Statut:
epublish
Résumé
The purpose of the Loma Linda University Health (LLUH) BREATHE cohort is to test the efficacy of a novel method of continuously incentivising participation in workplace smoking cessation on participation, long-term abstinence, health outcomes, healthcare costs and healthcare utilisation. In 2014, LLUH-a US academic medical centre and university-incentivised participation in a workplace smoking cessation programme (LLUH BREATHE) by lowering health plan costs. Specifically, LLUH introduced a Wholeness Health Plan (WHP) option that, for the smokers, continuously incentivises participation in nicotine screening and the LLUH BREATHE smoking cessation programme by offering an 'opt-in wellness discount' that consisted of 50%-53% lower out of pocket health plan costs (ie, monthly employee premiums, copayments). This novel 'continuously incentivised' model lowers annual health plan costs for smokers who, on an annual basis, attempt or maintain cessation from tobacco use. The annual WHP cost savings for smokers far exceed the value of short-term incentives that have been tested in workplace cessation trials to date. This ongoing health plan option offered to over 16 000 employees has created an open, dynamic LLUH BREATHE cohort of current and former smokers (n=1092). Our profile of the LLUH BREATHE cohort indicates that after 5 years of follow-up in a prospective cohort study (2014-2019), continuously incentivised smoking cessation produced a 74% participation (95% CI (71% to 77%)) in employer-sponsored smoking cessation attempts that were occurring less than a year after the incentive was offered. The cohort can be purposed to examine the effect of continuously incentivised cessation on cessation outcomes, health plan utilisation/costs, use of electronic nicotine delivery systems, and COVID-19 outcomes.
Identifiants
pubmed: 35450892
pii: bmjopen-2021-053303
doi: 10.1136/bmjopen-2021-053303
pmc: PMC9024252
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e053303Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Am J Respir Crit Care Med. 2016 Oct 15;194(8):981-988
pubmed: 27064456
MMWR Morb Mortal Wkly Rep. 2011 Nov 11;60(44):1513-9
pubmed: 22071589
JAMA. 2014 Mar 5;311(9):909-10
pubmed: 24493405
Cochrane Database Syst Rev. 2019 Feb 20;2:CD013272
pubmed: 30784046
N Engl J Med. 2015 May 28;372(22):2108-17
pubmed: 25970009
Proc Natl Acad Sci U S A. 2011 Sep 13;108 Suppl 3:15549-56
pubmed: 21508324
Cancer. 1989 Aug 1;64(3):570-81
pubmed: 2743251
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563
Arch Intern Med. 2001 Jul 9;161(13):1645-52
pubmed: 11434797
Cochrane Database Syst Rev. 2015 May 18;(5):CD004307
pubmed: 25983287
Tob Prev Cessat. 2020 Apr 07;6:23
pubmed: 32548360
Int J Epidemiol. 2008 Apr;37(2):260-5
pubmed: 17726038
Front Public Health. 2021 Mar 26;8:570458
pubmed: 33869121
Health Aff (Millwood). 2016 Jul 1;35(7):1176-83
pubmed: 27385231
Transl Stroke Res. 2020 Apr;11(2):161-164
pubmed: 32062815